OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR)

55 filings reported holding OKUR - OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share as of Q1 2025.
OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11.9M shares of 12.9M outstanding shares and own 92.77% of the company stock.
Largest 10 shareholders include Cormorant Asset Management, LP (1.84M shares), ACORN CAPITAL ADVISORS, LLC (1.44M shares), CITADEL ADVISORS LLC (1.07M shares), PERCEPTIVE ADVISORS LLC (1M shares), SAMSARA BIOCAPITAL, LLC (824K shares), VANGUARD GROUP INC (707K shares), Vestal Point Capital, LP (635K shares), Deep Track Capital, LP (524K shares), StepStone Group LP (492K shares), and NEA Management Company, LLC (479K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.